INTRODUCTION
============

Colorectal cancer (CRC) is a major cause of mortality.[@b1-gnl-11-667],[@b2-gnl-11-667] It is the second most commonly diagnosed cancer in Korea, after thyroid cancer,[@b3-gnl-11-667] where it accounts for 17% of newly diagnosed cancers.[@b4-gnl-11-667] Considering that the transition from premalignant to malignant status takes 10 to 15 years, early detection of CRC is crucial.[@b5-gnl-11-667] Colonoscopy is associated with lower CRC mortality rates[@b6-gnl-11-667],[@b7-gnl-11-667] and is a well-established screening modality, recommended for all individuals \>50 years old.[@b8-gnl-11-667] Because the prevalence of advanced adenoma and the incidence of CRC increases with age, advanced adenomas, implicated in the etiology of colon cancer, are a significant concern for the average-risk individual.

For the Korean population, one prospective study reported that the 3- and 5-year incidence of advanced adenoma recurrence after polypectomy in high-risk patients was 9.6% and 12.2%, respectively.[@b9-gnl-11-667] The presence of ≥3 adenomas and an adenoma size ≥1 cm were independent predictors for recurrent advanced colorectal neoplasia.[@b9-gnl-11-667] Two recent retrospective studies reported that age is a significant risk factor for developing colorectal neoplasms after removal of high-risk adenomas,[@b10-gnl-11-667] and that the presence of multiple high-risk findings was associated with an increased risk of advanced neoplasia during surveillance.[@b11-gnl-11-667]

The aims of this study were to determine the cumulative incidence of advanced neoplasia at follow-up colonoscopy in subjects who had undergone complete screening colonoscopy and removal of all polyps, and to identify the risk factors for advanced neoplasia according to risk components and adenoma location at index colonoscopy in asymptomatic subjects. We analyzed subsequent advanced neoplasia by risk components (≥3 adenomas, adenoma size ≥1 cm, and villous-type adenoma) and adenoma location at index colonoscopy.

MATERIALS AND METHODS
=====================

1. Study subjects
-----------------

A total of 11,930 subjects underwent cancer screening colonoscopy at the Health Promotion Center of Gangnam Severance Hospital between July 2007 and January 2012. Of these, we excluded those with baseline CRC; nonneoplastic polyps, such as hyperplastic or inflammatory polyps; those whose colonoscopy was incomplete; and subjects who did not undergo follow-up colonoscopy. Thus, we retrospectively analyzed 1,974 outpatients. For 1,588 of the 1,974 subjects (80.4%), the index colonoscopy was their first colonoscopy, whereas 225 subjects (11.4%) had undergone colonoscopy previously, and 161 (8.2%) had an unknown colonoscopy history. All 225 subjects with previous colonoscopy reported no significant findings (such as colon cancer) or colonic surgery. Polyps and adenomas detected during colonoscopy were removed by standard biopsy using forceps or by polypectomy. All colonoscopies were performed by six board-certified endoscopists, each of whom had performed \>3,000 colonoscopies and had an adenoma detection rate of \>25% for routine procedures.[@b8-gnl-11-667]

Subjects were grouped according to risk, based on the index colonoscopy findings, as follows: a high-risk group, subjects with advanced adenoma or ≥3 adenomas; a low-risk group, those with 1 to 2 adenomas \<1 cm in size; and a normal group, subjects with no colonic polyps (of any kind) at index colonoscopy. The cumulative incidence of advanced neoplasia at follow-up colonoscopy was determined stratified by risk group. The study was approved by the Yonsei University Gangnam Severance Hospital's Institutional Review Board (approval number: 3-2015-0040).

2. Variables and definitions
----------------------------

Colonic neoplasias were histopathologically confirmed as being either adenomas or adenocarcinomas. Advanced adenoma was defined as a lesion ≥1 cm in diameter, a lesion with villous or tubulovillous histologic characteristics, or a lesion with high-grade dysplasia.[@b12-gnl-11-667] Advanced neoplasia was defined as advanced adenoma or adenocarcinoma. Synchronous adenomas were evaluated and the size of the largest one was used in the analysis. The size of the adenomas was estimated using biopsy forceps. Right-sided colonic adenomas were defined as those occurring in the portion of the colon proximal to the splenic flexure. Colonic adenoma location was identified as left-sided only, right-sided only, and both right- and left-sided; right-sided adenomas comprised the latter two locations.

The following variables were analyzed for each patient: sex; age; laboratory results; and the number, size, location, and histology results of adenomas found and removed. The results of the fecal occult blood test (FOBT) and body mass index (BMI) were obtained from the medical records. BMI was dichotomized as ≥25 kg/m^2^ and \<25 kg/m^2^ for the analysis. Age was categorized as \<60 years and ≥60 years.

3. Statistical analysis
-----------------------

Characteristics of colonic neoplasia such as the size, location, pathology, and laboratory findings were compared using t-tests for continuous variables and chi-square tests for categorical variables. Continuous variables are presented as the mean±standard deviation (SD). We have presented the univariable and multiple regression models that included the relevant variables. For all comparisons, two-sided p-values \<0.05 were considered statistically significant, and 95% confidence intervals (CI) are given. The Kaplan-Meier method was used to describe the cumulative incidence of advanced neoplasia. Cox regression analysis was used to determine the hazard ratio (HR) of advanced neoplasia at follow-up colonoscopy according to relevant variables. Analyses were performed using the R Statistical Package version 3.1.2 (Institute for Statistics and Mathematics, Vienna, Austria; <http://www.R-project.org>) and SAS statistical software version 9.2 (SAS Institute Inc., Cary, NC, USA).

RESULTS
=======

1. Characterization of colonic neoplasia at index screening colonoscopy
-----------------------------------------------------------------------

The baseline characteristics of the 1,974 subjects are listed in [Table 1](#t1-gnl-11-667){ref-type="table"}. At baseline, the subjects' mean age was 55.7±7.1 years, and 72.1% were male. Overall, 1,400 subjects (70.9%) had colonic adenomas; 572 (29.0%) had ≥2 colonic adenomas, and 201 (10.2%) had advanced adenomas. There were 350 (17.7%), 1,050 (53.2%), and 574 (29.1%) subjects in the high-risk, low-risk, and normal group, respectively. In terms of age, 1,438 subjects (72.8%) were aged 40 to 59 years; 439 (22.2%) were aged 60 to 69 years; and 97 (4.9%) were aged ≥70 years. Right-sided colonic adenomas were seen in 851 of subjects overall (43.1%), and in 60.8% of the 1,400 subjects with colonic adenomas. Sixty-nine subjects (3.5%) had villous histology, 182 (9.2%) had adenomas ≥1 cm in size, and 239 (12.1%) had ≥3 adenomas. Of the 1,400 subjects with adenomas, 43 (3.07%) had serrated adenomas/polyps. In the low-risk group, 17 subjects (1.6%) had serrated adenomas, whereas 26 subjects (7.4%) in the high-risk group had serrated adenomas.

2. Advanced colonic neoplasia at follow-up colonoscopy
------------------------------------------------------

The mean follow-up period was 41.8±21.7 months. Overall, 111 subjects were diagnosed with advanced neoplasia (5.6%) during follow-up colonoscopy (after having undergone complete screening and removal of all polyps at the index colonoscopy). Of these, 58 subjects (52.3%) had ≥3 adenomas, 96 (86.5%) had lesions ≥1 cm in size, and 23 adenomas (20.7%) had villous histology. No significant difference in the location of these advanced neoplasms was observed between the right- (n=69, 62.2%) and left-sided (n=42, 37.8%) colon (p=0.219).

Six subjects were newly diagnosed with adenocarcinomas during follow-up colonoscopy ([Table 2](#t2-gnl-11-667){ref-type="table"}): one from the normal group, three from the low-risk group, and two from the high-risk group. All six adenocarcinomas were located in different sites from where adenomas were removed at the index colonoscopy; five were located in the right-sided colon (one in the sigmoid colon, two in the transverse colon, and three in the ascending colon). Two cases were treated with endoscopic submucosal dissection (both had adenocarcinoma *in situ* \[pTis\]); the others were treated surgically (two cases had submucosal \[pT1\] invasion and two cases had subserosal \[pT3\] invasion). One subject had metastases to the adrenal gland. After adjuvant chemotherapy, an extended right hemicolectomy with right adrenalectomy was performed. The final pathology was mucinous adenocarcinoma with serosal invasion.

3. Cumulative incidence of advanced neoplasia at follow-up colonoscopy
----------------------------------------------------------------------

Incidence of advanced neoplasia at the follow-up colonoscopy according to risk group are listed in [Table 3](#t3-gnl-11-667){ref-type="table"}. The 3-year cumulative incidences of advanced neoplasia stratified by risk group were as follows: high-risk group, 10.2% (95% CI, 0.86 to 0.94); low-risk group 3.1% (95% CI, 0.96 to 0.98); normal group 0.8% (95% CI, 0.98 to 1.00) (p\<0.0001). The corresponding 5-year cumulative incidences of advanced neoplasia were 20.2% (95% CI, 0.74 to 0.87); 8.6% (95% CI, 0.89 to 0.94); and 2.2% (95% CI, 0.96 to 0.99), respectively (p\<0.0001) ([Fig. 1](#f1-gnl-11-667){ref-type="fig"}). The 3-year cumulative incidence of advanced neoplasia stratified by age group was 40 to 59 years, 2.6% (95% CI, 0.96 to 0.98); 60 to 69 years, 4.6% (95% CI, 0.93 to 0.98); and ≥70 years, 10.0% (95% CI, 0.84 to 0.97) (p\<0.0001). The corresponding 5-year cumulative incidences were 6.7% (95% CI, 0.91 to 0.95); 10.0% (95% CI, 0.86 to 0.94); and 19.4% (95% CI, 0.70 to 0.92), respectively (p\<0.0001). Age ≥60 years, current smoking, FOBT positivity, right-sided colonic adenoma at index colonoscopy, low-risk group (vs normal), high-risk group (vs normal) and high-risk components (≥3 adenomas, adenoma ≥1 cm in size, villous type) were risk factors for subsequent advanced neoplasia in the univariable analysis.

In the multivariable analysis, age ≥60 years (vs \<60 years: HR, 1.78; 95% CI, 1.21 to 2.63), right-sided colonic adenomas (vs non-right-sided colonic adenomas: HR, 1.74; 95% CI, 1.13 to 2.66), ≥3 adenomas (vs no adenomas ≥3: HR, 2.00; 95% CI, 1.22 to 3.28), and adenoma ≥1 cm in size (vs no adenoma ≥1 cm: HR, 2.03; 95% CI, 1.20 to 3.44) at index colonoscopy were independent risk factors for recurrent advanced neoplasia at follow-up ([Table 4](#t4-gnl-11-667){ref-type="table"}).

DISCUSSION
==========

The incidence of CRC in Korea is increasing. The annual percentage change in age-standardized incidence rates between 1999 and 2009 was +6.2%.[@b3-gnl-11-667] The age-standardized mortality rates of CRC continue to increase, unlike those of other common cancers whose mortality rates have decreased in recent years.[@b13-gnl-11-667] The prevalence of colorectal neoplasms in Korean individuals aged 50 to 59 years was 30.1% for overall neoplasia and 6.7% for advanced neoplasia.[@b14-gnl-11-667] In this study, the proportion of subjects with adenomas increased significantly with age. Notably, a previous study reported that increasing age was associated with a higher prevalence of right-sided lesions.[@b14-gnl-11-667]

According to the Korean guidelines for postpolypectomy colonoscopic surveillance, patients should be considered at high risk for subsequent advanced neoplasia at surveillance colonoscopy when one or more of the following conditions have been detected at index colonoscopy: (1) 3 or more adenomas, (2) any adenoma larger than 10 mm, (3) any tubulovillous or villous adenoma, (4) any adenoma with high-grade dysplasia, and (5) any serrated polyps larger than 10 mm.[@b15-gnl-11-667] Adenomas located in the right side of the colon at index colonoscopy are of concern but not confirmed.

Two recent retrospective studies reported that age was a significant risk factor for developing colorectal neoplasms after removal of high-risk adenomas,[@b10-gnl-11-667] and that the presence of multiple high-risk findings was associated with an increased risk of advanced neoplasia during surveillance.[@b11-gnl-11-667] Concurring with the findings of a retrospective study conducted by the Intestinal Cancer Study Group of the Korean Association for the Study of Intestinal Diseases,[@b10-gnl-11-667] we also found that in the multivariate analysis, age ≥60 years was a significant risk factor for advanced colorectal neoplasia following complete screening colonoscopy with removal of all polyps.

Chung *et al*.[@b9-gnl-11-667] reported in a prospective study that the 5-year and 3-year incidence of advanced adenoma among high-risk patients was 12.2% and 9.6%, respectively, after adenoma removal. In the present study, the 5-year and 3-year incidence of advanced neoplasia at follow-up colonoscopy in the high-risk group was 20.2% and 10.2%, respectively. Follow-up colonoscopy at 3 years is recommended for patients with any of the following: ≥3 adenomas, a tubular adenoma ≥1 cm in size, a villous adenoma ≥1 cm in size, and an adenoma with high-grade dysplasia.[@b16-gnl-11-667] In the Asia Pacific Consensus, a risk-stratified scoring system is recommended for selecting factors indicating high-risk for CRC and advanced neoplasia.[@b17-gnl-11-667] The scoring system includes age (50 to 69 years vs ≥70 years), male sex, having a first-degree relative with CRC, and current or past smoking.[@b17-gnl-11-667] Low-risk is defined as having 0 to 1 criterion; intermediate-risk, 2 to 3 criteria; and high-risk, 4 to 7 criteria.[@b17-gnl-11-667] In this study, after adjustment for age, sex, family history of CRC, smoking, BMI \>25 kg/m^2^, FOBT positivity, ≥3 adenomas, adenoma ≥1 cm in size, villous component, and adenoma location, the following factors at index colonoscopy were significant risk factors for advanced neoplasia at follow-up colonoscopy: age ≥60 years, ≥3 adenomas, adenoma ≥1 cm in size, and any right-sided colonic adenoma. Although the presence of right-sided colonic adenomas at index colonoscopy was not considered as a high risk condition for subsequent advanced neoplasia at surveillance colonoscopy, the trend toward a greater number of adenomas missed in the right-side colon compared with the left was of concern.[@b18-gnl-11-667]

In the subanalysis, right-sided only colonic adenomas were significant in the multivariable analysis ([Supplementary Table 1](#s1-gnl-11-667){ref-type="supplementary-material"}). Age ≥60 years, right-sided only colonic adenoma, ≥3 adenomas, and adenoma ≥1 cm in size were also significant risk factors for advanced adenoma at follow-up colonoscopy. Hence, we presented that any right-sided colonic adenoma is significant for subsequent advanced neoplasia. However, no significant difference in the location of subsequent advanced neoplasia was observed between the right- (62.2%) and left-sided colon (37.8%) (p=0.219). At index colonoscopy, right-sided only adenoma was seen in 45.2% of subjects in the low-risk group and in 19.1% of subjects in the high-risk group, while both right- and left-sided adenomas were seen in 10.4% and 57.2% of subjects in the low-risk and high-risk group, respectively. This difference at index colonoscopy could affect the outcome. Otherwise, bacterial biofilms are associated with CRC and microbiota organization is a distinct feature of proximal CRCs;[@b19-gnl-11-667] the location of baseline adenomas could be a risk factor for advanced colonic neoplasia, but further studies are needed.

There were six (male) subjects who had adenocarcinomas diagnosed at follow-up colonoscopy. These adenocarcinomas were located in the right-sided colon in five of the six subjects (83%).

There are several possible reasons for these six subsequent colonic cancers detected at follow-up colonoscopy. First, it is possible that lesions were missed at the index colonoscopy. Right-sided sessile serrated adenomas or spreading-type advanced lesions are easy to miss. In these six patients, ulcerative type (n=1), ulcero-infiltrative type (n=1), ulcero-fungating type (n=1), and laterally spreading tumor nongranular type (n=3) was tumors were seen, these lesions could have been missed at index colonoscopy. Second, incomplete resection of a lesion is possible. At index colonoscopy, four cases were treated with biopsy removal and one with polypectomy. Even though complete resection was reported in the polypectomy case, a remnant lesion at the biopsy site could be the reason for interval cancer. Third, new lesions or rapid progression is possible. A CIMP (CpG island methylator phenotype)-high/BRAF (B-type Raf kinase) mutation or microsatellite instability could result in rapid progression of cancer after dysplasia, or a sessile-serrated adenoma/polyp could be a precursor of interval cancer. Sessile-serrated adenomas/polyps are more prevalent in the right-sided colon. Moreover, 83% of follow-up colon cancers were right-sided in this study. Last, inappropriate withdrawal time at index colonoscopy is a possible reason for interval cancer. The withdrawal time of 618 index colonoscopies (31.3%) was \<6 minutes (colonoscopy procedure time: mean±SD, 13.5±6.2 minutes; withdrawal time: mean±SD, 7.9±5.0 minutes). A withdrawal time of \<6 minutes was mostly noted from 2007 to 2009 (85.9%).

The current study had several limitations. It was retrospective and conducted at a single center; it was not population based. It included individuals who underwent regular health examinations, which could have introduced selection bias and the potential for incomplete data. Follow-up duration also varied. We could not measure other confounders, such as food intake and consumption. Those who underwent screening were funded by employers (60%) or were self-funded (40%), and may have been more health conscious than the general population.[@b20-gnl-11-667] The incidence of lesions, chance of missed lesions, or incomplete removal at initial screening colonoscopy was possible.[@b21-gnl-11-667] The Boston Bowel Preparation Scale was applied for assessment of the quality of bowel preparation in 2011; prior to that, data were subjectively categorized by the endoscopist as "excellent," "good," "fair," and "poor." Although subjects with "excellent," "good" and "fair" bowel preparation were analyzed, these terms lacked standardized definitions. Nevertheless, considering the emerging interest in interval colon cancer in patients, advanced neoplasia at follow-up colonoscopy according to risk group, risk components and baseline adenoma location was useful in furthering the understanding of advanced neoplasia in the average-risk individual.

In conclusion, the 3-year cumulative incidence of advanced neoplasia by risk group was 10.2%, 3.1%, and 0.8% in the high-risk, low-risk, and normal group, respectively. The corresponding 5-year cumulative incidences were 20.2%, 8.6%, and 2.2%, respectively. In terms of high-risk components, ≥3 adenomas, adenomas ≥1 cm, any right-sided colonic adenoma, and age ≥60 years at index colonoscopy were significant risk factors for advanced neoplasia at follow-up colonoscopy. Further studies are needed for adenoma location, especially right-sided colonic location, and subsequent advanced neoplasia.
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==================
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![Cumulative incidence of recurrent advanced neoplasia according to risk group at the index colonoscopy. The 3-year cumulative incidence of advanced neoplasia in each risk group was 10.2% in the high-risk group (advanced neoplasia or ≥3 adenomas; 95% confidence interval \[CI\], 0.86--0.94), 3.1% in the low-risk group (1--2 adenomas \<1 cm in size; 95% CI, 0.96--0.98), and 0.8% in the normal group (95% CI, 0.98--1.00) (p\<0.0001). The 5-year cumulative incidence of advanced neoplasia in each risk group was 20.2% in the high-risk group (95% CI, 0.74--0.87), 8.6% in the low-risk group (95% CI, 0.89--0.94), and 2.2% in the normal group (95% CI, 0.96--0.99) (p\<0.0001).](gnl-11-667f1){#f1-gnl-11-667}

###### 

Comparison of Baseline Characteristics among Subjects Who Underwent a Follow-up Colonoscopy

  Characteristic                        Overall (n=1,974)   Normal group (n=574)   Low-risk group (n=1,050)   High-risk group (n=350)   p-value
  ------------------------------------- ------------------- ---------------------- -------------------------- ------------------------- ----------
  Age, yr                               55.7±7.1            53.3±6.4               56.1±6.8                   58.3±7.6                  \<0.0001
  Male sex                              1,423 (72.1)        379 (66.0)             768 (73.1)                 276 (78.9)                \<0.0001
  Follow-up duration, mo                41.8±21.7           49.5±23.7              38.9±20.1                  37.7±19.6                 \<0.0001
  2 Or more adenomas                    572 (29.0)          \-                     279 (26.6)                 293 (83.7)                \<0.0001
  Advanced adenoma                      201 (10.2)          \-                     \-                         201 (57.4)                
  Age group, yr                                                                                                                         \<0.0001
   40--59                               1,438 (72.9)        475 (82.8)             753 (71.7)                 210 (60.0)                
   60--69                               439 (22.2)          86 (15.0)              241 (23.0)                 112 (32.0)                
   ≥70                                  97 (4.9)            13 (2.2)               56 (5.3)                   28 (8.0)                  
  Adenoma location                                                                                                                      \<0.0001
   Right-sided only                     542 (27.5)          \-                     475 (45.2)                 67 (19.1)                 
   Left-sided only                      549 (27.8)          \-                     466 (44.4)                 83 (23.7)                 
   Both RT and LT                       309 (15.7)          \-                     109 (10.4)                 200 (57.2)                
  Villous component                     69 (3.5)            \-                     \-                         69 (19.7)                 
  Adenoma ≥1 cm                         182 (9.2)           \-                     \-                         182 (52.0)                
  ≥3 Adenomas                           239 (12.1)          \-                     \-                         239 (68.3)                
  Current smoking                       320 (16.2)          71 (12.4)              175 (16.7)                 74 (21.1)                 0.002
  Family history of colorectal cancer   79 (4.0)            20 (3.5)               46 (4.4)                   13 (3.7)                  0.648
  Withdrawal time, min                  7.9±5.0             4.6±2.4                8.3±3.6                    12.2±5.8                  \<0.001

Data are presented as mean±SD or number (%).

RT, right side of the colon; LT, left side of the colon.

###### 

Summary of the Six Patients with Newly Diagnosed Colonic Adenocarcinoma at Follow-up Colonoscopy

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No   Age/sex   Risk group                                       Withdrawal time, min   Interval, mo[\*](#tfn5-gnl-11-667){ref-type="table-fn"}   Adenocarcinoma location, size, type in follow-up colonoscopy   TNM stage                                   Treatment
  ---- --------- ------------------------------------------------ ---------------------- --------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------- ----------------------------------
  1    68/M      Low                                              8                      23.9                                                      Ascending colon, 1.2 cm, LST NG type                           pT1N0M0\                                    (Laparoscopic)\
                                                                                                                                                                                                                  Adenocarcinoma, well differentiated         Right hemicolectomy

  2    58/M      Low                                              8                      12.0                                                      Ascending colon, 2.5 cm, LST NG type                           pTis\                                       Endoscopic submucosal dissection
                                                                                                                                                                                                                  Adenocarcinoma, well differentiated         

  3    60/M      Low                                              13                     35.7                                                      Sigmoid colon, 2.5 cm, ulcerofungating                         pT3N1M0\                                    (Laparoscopic)\
                                                                                                                                                                                                                  Adenocarcinoma, moderately differentiated   Low anterior resection

  4    73/M      High[†](#tfn6-gnl-11-667){ref-type="table-fn"}   14                     29.7                                                      Transverse colon, 1.0 cm, LST NG type                          pTis\                                       Endoscopic submucosal dissection
                                                                                                                                                                                                                  Adenocarcinoma, well differentiated         

  5    57/M      High                                             15                     68.8                                                      Ascending colon, 3.0 cm, ulcero-infiltrative                   pT3N2aM1\                                   Extended right hemicolectomy\
                                                                                                                                                                                                                  Mucinous adenocarcinoma                     Right adrenalectomy

  6    70/M      Normal                                           \<6                    54.2                                                      Transverse colon, 1.0 cm, ulcerative                           pT1N0M0\                                    (Laparoscopic)\
                                                                                                                                                                                                                  Adenocarcinoma, well differentiated         Transverse colectomy
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TNM stage, depth of invasion: submucosa (pT1), subserosa (pT3), adenocarcinoma *in situ* (pTis).

M, male; LST NG, laterally spreading tumor, nongranular.

Months between the index screening colonoscopy and follow-up colonoscopy at which cancer was detected;

Polypectomy in the index colonoscopy with pathology-proven complete resection of the adenoma.

###### 

Incidence of Advanced Neoplasia at Follow-up Colonoscopy According to Risk Group (p\<0.0001)

  Follow-up duration, mo   Normal group (n=574)   Low-risk group (n= 1,050)   High-risk group (n=350)                                            
  ------------------------ ---------------------- --------------------------- ------------------------- ----- ------ -------------- ----- ------ --------------
  36                       367                    0.8                         0.984--1.000              543   3.1    0.957--0.982   179   10.2   0.861--0.936
  48                       322                    1.4                         0.975--0.997              374   5.2    0.930--0.967   102   15.7   0.793--0.895
  60                       238                    2.2                         0.962--0.994              187   8.6    0.885--0.944   61    20.2   0.736--0.866
  72                       188                    2.7                         0.954--0.992              80    12.2   0.834--0.925   23    28.7   0.612--0.830

No. risk, numbers of subjects at risk; CI, confidence interval.

###### 

Relative Risks of Advanced Neoplasia at the Follow-up Colonoscopy According to the Characteristics at the Index Colonoscopy

  Characteristic                                     Univariable analysis    Multivariable analysis                          
  -------------------------------------------------- ----------------------- ------------------------ ---------------------- -------
  Age, yr                                                                                                                    
   \<60                                              1                                                1                      
   ≥60                                               2.090 (1.4436--3.043)   0.0001                   1.781 (1.208--2.625)   0.004
  Sex                                                                                                                        
   Female                                            1                                                1                      
   Male                                              1.156 (0.744--1.794)    0.519                    0.854 (0.536--1.359)   0.505
  Family history of colorectal cancer                                                                                        
   No                                                1                                                1                      
   Yes                                               1.356 (0.553--3.325)    0.506                    1.521 (0.610--3.796)   0.369
  Current smoking                                                                                                            
   No                                                1                                                1                      
   Yes                                               1.592 (1.019--2.486)    0.041                    1.451 (0.897--2.347)   0.129
  BMI ≥25 kg/m^2^                                                                                                            
   No                                                1                                                1                      
   Yes                                               1.101 (0.745--1.626)    0.629                    1.082 (0.728--1.608)   0.698
  Stool occult blood test positivity                                                                                         
   No                                                1                                                1                      
   Yes                                               2.040 (1.094--3.806)    0.025                    1.205 (0.610--2.381)   0.591
  Right-sided colonic adenoma at index colonoscopy                                                                           
   No                                                1                                                1                      
   Yes                                               2.646 (1.803--3.883)    \<0.0001                 1.736 (1.131--2.664)   0.012
  Risk groups                                                                                                                
   Normal                                            1                                                                       
   Low-risk                                          3.391 (1.867--6.161)    \<0.0001                                        
   High risk                                         9.103 (4.966--16.686)   \<0.0001                                        
  High-risk component                                                                                                        
   ≥3 Adenomas (vs no adenomas ≥3)                   3.880 (2.576--5.844)    \<0.0001                 2.000 (1.218--3.282)   0.006
   Adenoma ≥1 cm (vs no adenoma ≥1 cm)               3.814 (2.469--5.891)    \<0.0001                 2.034 (1.204--3.436)   0.008
   Villous type (vs no villous adenoma)              3.730 (1.999--6.961)    \<0.0001                 1.130 (0.544--2.348)   0.743

HR, hazard ratio; CI, confidence interval; BMI, body mass index.
